Pregnancy Clinical Trial
Official title:
Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy
We hypothesized that vitamin D supplementation during pregnancy can prevent adverse pregnancy outcome.
Vitamin D deficiency has been associated with many chronic diseases. These include
cardiovascular diseases, diabetes mellitus, multiple sclerosis, breast and prostate cancers.
Recently, its role in pregnancy has been explored. Vitamin D deficiency has been found to be
associated with adverse pregnancy outcome. These include pre eclampsia, gestational diabetes
mellitus, preterm labor and low birth weight.
Bodnar et al, evaluated role of vitamin D deficiency during pregnancy in PE in a nested case
control study. The investigators looked at the role of vitamin D at gestational age of < 22
weeks. Women who developed PE were found to have low levels of vitamin D. These women had
serum levels of vitamin D < 15 ng/ml, were supplemented during pregnancy with prenatal
vitamins, were still found to have 5 fold greater chances of developing PE (adjusted odds
ratio, 5.0; 95% confidence interval, 1.7-14.1).Children of above group of women were also
found to have low levels of vitamin D. The authors concluded that vitamin D deficiency may
be an independent factor for the development of PE.(1)
In an epidemiological study from Norway, involving 23,423 primigravidae, the rsik of PE was
found to be 27% greater in women who did not receive D supplements, compared to women who
received 10-15µg/day of vitamin D(2).
Circulating levels of 1-25(OH) have been found to be low in women with PE.(3) This has been
attributed to reduced expression and activity of 1α-hydroxylase in human placenta from
preeclamptic pregnancies.(4) This association with PE has also been found to be influenced
by VEGF (Vascular endothelial growth factor). Active forms of vitamin D have been found to
increase the expression of VEGF , and its release in vascular smooth cells, in in-vitro
studies.(5)
Vitamin D deficiency has also been associated with small for gestational age (SGA) (6) The
difference has been found to be more subtle for Caucasians as compared to African-Americans
in West. The investigators showed a U shaped association between D levels and SGA. After
confounder adjustment, compared with serum 25(OH)D 37.5-75 nmol/L, SGA odds ratios (95% CI)
for levels <37.5 and >75 nmol/L were 7.5 (1.8, 31.9) and 2.1 (1.2, 3.8), respectively. In a
similar study by Brooke, among Asian women resident in UK, vitamin D supplementation with
1000IU in third trimester, compared with placebo, was associated with decreased incidence of
small for gestational age (15% versus 29%). Investigators suggested supplementation with
vitamin D among Asians living in UK.(7)
Vitamin D deficiency has been related to gestational diabetes mellitus (GDM) in pregnant
women. Zhang et al, found that vitamin D deficiency in early pregnancy is linked with
increased risk for GDM. Vitamin D deficiency was associated with a 2.66-fold (OR (95% CI):
2.66 (1.01-7.02)) increased GDM risk. Moreover, each 5 ng/ml decrease in 25-[OH] D
concentrations was related to a 1.29-fold increase in GDM risk (OR (95% CI): 1.29
(1.05-1.60)).(8) Similarly, in an Iranian study, women who were found to have GDM, were
found to have lower levels of serum 1,25 (OH), as compared to normoglycemic women. (9) Serum
levels of <12 nmol/L were found associated with GDM. This may be linked to the fact that
1,25(OH) stimulates insulin secretion.
Vitamin D deficiency has also been linked to increased risk for cesarean section. In a study
of 253 women, who underwent cesarean section, multivariable logistic regression analysis
controlling for race, age, education level, insurance status, and alcohol use, women with
25(OH)D less than 37.5 nmol/liter were almost 4 times as likely to have a cesarean than
women with 25(OH)D 37.5 nmol/liter or greater (adjusted odds ratio 3.84; 95% confidence
interval 1.71 to 8.62).(10) Poor muscular performance due to vitamin D deficiency may be the
reason for the increased cesarean section rate.
Preterm labor, is the other adverse pregnancy outcome, which is thought to be affected by
maternal serum levels of 1,25(OH). In a recently concluded RCT, a comparison was made
between 400IU, 2000IU and 4000IU of daily supplementation with vitamin D. Women who were
prescribed highest doses had significant less chances of spontaneous preterm birth at < 37
and at < 32 weeks.(11) Inflammation plays a key role in the etiology of preterm labor. And
vitamin D is known to influence the production of inflammatory mediators like interleukin 1,
interleukin -6 and tumor necrosis factor by macrophages.(12) This may be a reason for
decreased incidence of preterm birth in women who received vitamin D supplementation.
Birth weight of newborn is also affected by maternal serum D levels. In a study from
neighboring Iran, of 449 women, birth weight, length and apgar score were significantly
better in women who took diet adequate in calcium and vitamin D.(13) Vitamin D
supplementation during pregnancy leads to increased calcium stores in infants and improved
weight gain as well. Levels < 25ng/ml are associated with rickets and osteomalacia. There is
positive correlation between maternal and neonatal cord levels of vitamin D. This
relationship has also been shown in studies from other part of world. (14-16)This indicates
that these newborns are entering the world, with deficiency of vitamin D, which starts in
utero. Apart from affecting skeletal development, it also affects the innate immune system
of newborn. In a case-control study, children who were deficient in vitamin D were found to
be more prone to acute respiratory tract infections. The mean serum 25(OH)D concentrations
in the study group newborns were lower than those of the control group (9.12+/-8.88 ng/ml
and 16.33+/-13.42 ng/ml, respectively) (P=0.011). (17) It has been observed that infants
born to D replete mothers will become D deficient, 8 weeks after birth, unless they are
supplemented with vitamin D. In an earlier cross sectional study, from Karachi city Atiq M,
had found low levels of vitamin D in newborns who were breastfed. The age group was from 6
weeks to 11 months. Thirty-four (48%) mothers and 37 (52%) infants had levels less than 25
nmol/ L (i.e. <10ng/ml). The investigators found a significant correlation between serum
25(OH)D levels of infants under three months of age and their mothers (p<0.01).(18) Though
this study was carried out in a private university hospital, where majority of mothers
belonged to upper socio economic class.
Content of vitamin D in breast milk is dependant upon the serum levels in mothers.
Supplementation of lactating mothers has been recommended to avoid deficiency in newborn,
but is not a norm in our practice. There is also increased motivation for exclusive breast
feeding for the first 4-6 months in our society. Hence with prevalence of vitamin D
deficiency as high as 90% in our population (data submitted for publication), our newborns
are more at risk for vitamin D deficient rickets
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02520687 -
Effects of Dietary Nitrate in Hypertensive Pregnant Women
|
Phase 1 |